Global Demand Insights Senior Associate
Amgen
Global Demand Insights Senior Associate
Amgen
Makes biotech medicines for serious illnesses
Role Summary
The Senior Associate, Demand Insights supports Amgen's Global Supply Chain organization by generating demand analytics, forecasting insights, and performance indicators that enhance demand signal understanding, improve the consensus forecasting process and inform business decisions that ensure supply while optimizing cost.
This role will report into the Global Demand Insights Manager, within Amgen’s Capability Center with a focus on integrating global product-level forecasts, sales and marketing data with regional and country perspectives to identify trends and support country engagement leads in scenario planning to drive alignment between commercial expectations, supply strategies, and the Integrated Business Planning (IBP) process.
The successful candidate will demonstrate strong analytical capability, leverage demand planning systems, statistical forecasting methods, and analytical tools to transform complex data into actionable insights that improve forecast quality, support Integrated Business Planning (IBP), and ensure alignment between commercial expectations and supply chain strategies.
Key Responsibilities
Demand Analytics & Insight Generation
Forecast Performance Monitoring
Statistical Forecasting & Scenario Analysis
Demand Planning Systems & Data Management
Continuous Improvement
Cross-Functional Collaboration
Basic Qualifications
Preferred Qualifications
Key Performance Indicators
Our Commitment
At Amgen, we empower our teams to turn insights into impact. The Global Demand Sr Associate will play a pivotal role in connecting data, analytics, and business strategy — ensuring that every forecast informs meaningful action to better serve patients worldwide.
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen